{"product_id":"trueage-cellular-baseline","title":"TrueAge Cellular Baseline","description":"\u003cdiv style=\"background: #f8f9fa; border-left: 4px solid #0057a8; padding: 12px 16px; margin-bottom: 20px;\" id=\"ai-summary\"\u003e\n\u003cstrong\u003eClinical Summary:\u003c\/strong\u003e The TrueAge Cellular Baseline is an epigenetic age assessment service that quantifies biological age via genome-wide DNA methylation analysis across 900,000+ CpG sites, applying validated longevity clocks including GrimAge, PhenoAge, and the Horvath clock to establish an individual's true cellular ageing rate. The test is processed by a CLIA-certified laboratory and benchmarks results against population-level methylation reference datasets to identify discordance between chronological and biological age. It is indicated for longevity medicine practitioners, preventive health programmes, and individuals undertaking targeted anti-ageing interventions who require a quantitative cellular baseline prior to and following lifestyle or therapeutic modifications.\u003c\/div\u003e\n\u003ch2\u003eProduct Overview\u003c\/h2\u003e\n\u003cp\u003eThe TrueAge Cellular Baseline is a foundational epigenetic assessment available through EMIS+ in Singapore, designed to measure biological age at the molecular level using DNA methylation — the most validated epigenetic mechanism of cellular ageing. Unlike conventional blood biomarker panels, DNA methylation patterns across specific CpG loci change predictably and reproducibly with age, and deviations from expected methylation trajectories correlate with increased all-cause mortality, cardiometabolic disease burden, and functional decline. The test analyses over 900,000 CpG methylation sites to compute multiple validated biological age metrics, providing an objective and quantitative assessment of how rapidly an individual is ageing at the cellular level relative to chronological age.\u003c\/p\u003e\n\u003cp\u003eThe assessment employs the Illumina EPIC microarray platform within a CLIA-certified and HIPAA-compliant laboratory environment, ensuring analytical validity, chain-of-custody documentation, and data protection standards consistent with international clinical laboratory requirements. Results are interpreted via five established epigenetic clocks — GrimAge v2 (most predictive of all-cause mortality), PhenoAge (correlated with phenotypic age), Horvath v1 and v2 (pan-tissue clocks), and DunedinPACE (current pace of ageing) — alongside an immune cell composition report derived from methylation-based cell deconvolution. This multi-clock approach eliminates single-clock bias and enables nuanced longitudinal tracking of cellular ageing velocity over time.\u003c\/p\u003e\n\u003ch2\u003eSpecifications\u003c\/h2\u003e\n\u003ctable style=\"width: 100%; border-collapse: collapse; font-size: 14px;\" cellspacing=\"0\" cellpadding=\"8\" border=\"1\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eService Provider\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eTruDiagnostic (Lexington, KY, USA); distributed by EMIS + Singapore\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAnalytical Platform\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eIllumina Infinium MethylationEPIC BeadChip (850K+ CpG sites)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eEpigenetic Clocks Reported\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eGrimAge v2, PhenoAge, Horvath v1\/v2, DunedinPACE, PCPhenoAge\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCpG Sites Analysed\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e900,000+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eSample Type\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003ePeripheral blood (dried blood spot or venepuncture)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eTurnaround Time\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e4–6 weeks from sample receipt\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eLaboratory Accreditation\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCLIA-certified (Certificate of Compliance); HIPAA-compliant data handling\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eISO Compliance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eLaboratory operations aligned with ISO 15189:2022 principles for medical laboratory quality\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRegulatory Status (Singapore)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eWellness and longevity assessment service; not an IVD medical device under HSA Health Products Act 2007\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eReports Included\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBiological age, pace of ageing, organ system age (11 systems), immune cell deconvolution, telomere length estimate\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eReference Population\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eMulti-ethnic population cohort (10,000+ samples); Asian-representative subgroup included\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch2\u003eClinical Indications and Applications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eLongevity medicine baseline:\u003c\/strong\u003e Establishing a quantitative epigenetic age baseline for individuals entering structured anti-ageing or longevity optimisation programmes, enabling objective tracking of cellular age response to interventions.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMetabolic and cardiometabolic risk stratification:\u003c\/strong\u003e Identifying biological age acceleration in individuals with normal clinical markers but elevated epigenetic risk scores, particularly GrimAge discordance, which is independently predictive of cardiovascular events.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCorporate preventive health programmes:\u003c\/strong\u003e Integration into executive health screening packages in Singapore where employers seek objective biological age data to complement conventional health screening panels.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePost-intervention efficacy monitoring:\u003c\/strong\u003e Paired baseline and follow-up testing (recommended at 6–12 month intervals) to quantify cellular age response to caloric restriction, exercise protocols, metformin, NMN\/NAD+ supplementation, or senolytics.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImmune ageing and immunosenescence assessment:\u003c\/strong\u003e Methylation-based immune cell deconvolution to evaluate the ratio of naive to exhausted T-cell populations, relevant in oncology surveillance, post-COVID recovery programmes, and vaccine response evaluation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePre-surgical and anaesthetic risk refinement:\u003c\/strong\u003e Supplementary biological age data for anaesthetists assessing frailty and physiological reserve in patients whose chronological age does not reflect functional status.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eQ: How does DNA methylation-based biological age differ from telomere length testing?\u003c\/strong\u003e\u003cbr\u003eA: Telomere length testing measures the average length of chromosome end-caps and is subject to significant inter-cell variability and technical noise. DNA methylation clocks analyse specific CpG locus patterns across hundreds of thousands of genomic sites, providing a more reproducible and statistically robust measurement. GrimAge, in particular, has been validated in multiple prospective cohort studies as the strongest epigenetic predictor of all-cause mortality, outperforming telomere length and most conventional biomarkers for this application.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: What is the clinical significance of a biological age that exceeds chronological age?\u003c\/strong\u003e\u003cbr\u003eA: Epigenetic age acceleration — where biological age is greater than chronological age — has been associated with increased risk of type 2 diabetes, cardiovascular disease, neurodegeneration, and all-cause mortality in meta-analyses involving hundreds of thousands of participants. A discordance of more than 3–5 years is generally considered clinically meaningful and warrants investigation of modifiable lifestyle, metabolic, and inflammatory factors. Practitioners should interpret results in the context of full clinical assessment rather than in isolation.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: How is the TrueAge Cellular Baseline conducted in Singapore?\u003c\/strong\u003e\u003cbr\u003eA: The service is fulfilled through EMIS+ in Singapore. Following purchase, a collection kit is dispatched; the blood sample can be collected via a home dried-blood-spot kit or at a participating phlebotomy centre. Samples are shipped to the TruDiagnostic CLIA-certified laboratory in the United States, with results returned digitally via a secure portal within 4–6 weeks of sample receipt.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Is this test registered with the Health Sciences Authority (HSA) Singapore?\u003c\/strong\u003e\u003cbr\u003eA: The TrueAge Cellular Baseline is a wellness and longevity assessment service rather than an in vitro diagnostic (IVD) medical device as defined under the HSA Health Products (Medical Devices) Regulations 2010. It is not used for the diagnosis, monitoring, or treatment of a specific disease and therefore does not require product registration with HSA. Practitioners should communicate this distinction to patients, particularly in clinical contexts requiring regulatory-grade diagnostics.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: What is the recommended testing frequency for longitudinal tracking?\u003c\/strong\u003e\u003cbr\u003eA: The consensus recommendation from longevity medicine practitioners and the scientific advisory board of TruDiagnostic is to retest at 6–12 month intervals following baseline assessment. This interval is aligned with the timescale over which meaningful epigenetic changes in response to lifestyle or pharmacological interventions are detectable. Shorter intervals may not capture biologically significant changes and are generally not recommended for routine monitoring.\u003c\/p\u003e\n\n\u003cscript type=\"application\/ld+json\"\u003e\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@type\": \"FAQPage\",\n  \"mainEntity\": [\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What is TrueAge Cellular Baseline used for?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"TrueAge Cellular Baseline by EMIS + is an ostomy care product designed to support stoma management and protect peristomal skin. It is suitable for use with colostomy, ileostomy, and urostomy pouching systems. For personalised advice on your pouching system, consult a Wound, Ostomy and Continence (WOC) nurse at SGH, NUH, CGH, or TTSH in Singapore.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Is TrueAge Cellular Baseline suitable for all stoma types — colostomy, ileostomy, and urostomy?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Most EMIS + stoma care products are designed to be compatible with all stoma types. However, the right product depends on your individual stoma location, output type, and skin condition. An enterostomal therapist (ET nurse) at a Singapore hospital can help you select the most appropriate products for your specific pouching system.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"How do I use TrueAge Cellular Baseline correctly?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Always refer to the product instructions included with TrueAge Cellular Baseline. In general, ensure peristomal skin is clean and dry before application, measure your stoma accurately, and change your pouching system every 1–3 days or when leakage is suspected. If you experience peristomal skin irritation, soreness, or persistent leakage, contact a WOC nurse or EMIS+ team for advice.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Where can I buy TrueAge Cellular Baseline in Singapore?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"TrueAge Cellular Baseline is available from EMIS+ at emis.asia — Singapore's trusted nurse-led stoma supply store. We stock a comprehensive range of ostomy products with fast island-wide delivery. Bulk orders for home care and nursing facilities are welcome. Contact us at emis.asia\/pages\/contact.\"\n      }\n    }\n  ]\n}\n\u003c\/script\u003e","brand":"EMIS +","offers":[{"title":"Default Title","offer_id":43525723553870,"sku":null,"price":450.0,"currency_code":"SGD","in_stock":true}],"url":"https:\/\/www.emis.asia\/zh\/products\/trueage-cellular-baseline","provider":"EMIS +","version":"1.0","type":"link"}